Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction undergoing primary angioplasty: Relation to left ventricular function and clinical outcome

Zeitschrift fur Kardiologie

Volumn 92, Issue 1, 2003, Pages 73-81

  Hartmann, F ^a   Kurowski, V ^a   Maghsoudi, A ^a   Kurz, T ^a   Schwarz, M ^a   Bonnemeier, H ^a   Tolg R ^a   Jain, D ^a   Wiegand, U ^a   Katus, H ^a   Richardt, G ^a  

^a Medizinische Klinik II   (Germany)

Author keywords

Angioplasty; Catecholamines; Myocardial infarction; Natriuretic peptides; Prognosis

Indexed keywords

ADRENALIN; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; NEUROHORMONE; NORADRENALIN;

ADULT; AMINO TERMINAL SEQUENCE; ANGIOPLASTY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DRESSLER SYNDROME; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REPERFUSION; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EPINEPHRINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12244301216     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0885-8     Document Type: Article

References (27)

1. Gazes PC, Richardson JA, Wood EF (1959) Plasma catecholamine concentrations in myocardial infarction and angina pectoris. Circulation 19:657-661
2. McDonald L, Baker C, Bray C, McDonald A, Restieaux N (1969) Plasma catecholamines after myocardial infarction. Lancet ii:1021-1023
3. McAlpine HM, Morton II, Leckie B, Rumley A, Gillen G, Dargie HJ (1988) Neuroendocrine activation after acute myocardial infarction. Br Heart J 60:117-124
4. Sigurdsson A, Held P, Swedberg K (1993) Short- and long-term neurohormonal activation following acute myocardial infarction. Am Heart J 126:1068-1076
5. Rouleau JL, de CJ, Klein M et al (1993) Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol 22:390-398
6. Francis GS, Benedict C, Johnstone DE et al (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82:1724-1729
7. Rouleau J-L, Packer M, Moye L et al (1994) Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 24:583-591
8. Omland T, Aarsland T, Aakvaag A, Lie RT, Dickstein K (1993) Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am J Cardiol 72:255-259
9. Hall C, Rouleau JL, Moye L et al (1994) N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 89:1934-1942
10. Hall C, Cannon CP, Forman S, Braunwald E (1995) Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators. J Am Coll Cardiol 26:1452-1456
11. Arakawa N, Nakamura M, Aoki H, Hiramori K (1996) Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27:1656-1661
12. Omland T, Aakvaag A, Bonarjee VV, et al (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93:1963-1969
13. Richards AM, Nicholls MG, Yandle TG et al (1999) Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group. Heart 81:114-120
14. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA (1997) Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 47:287-296
15. Richards AM, Nicholls MG, Yandle TG et al (1998) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97:1921-1929
16. Talwar S, Squire IB, Downie PF et al (2000) Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. Eur Heart J 21:1514-1521
17. The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 312:932-936
18. Sheehan FH, Doerr R, Schmidt WG et al (1988) Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinent of survival. J Am Coll Cardiol 12:289-300
19. Schoemig A, Fischer S, Kurz T, Richardt G, Schoemig E (1987) Non-exocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanisms and metabolic requirements. Circ Res 60:194-205
20. Drew PJ, Ilstrup DM, Kerin MJ, Monson JRT (1999) Prognostic factors: guidelines for investigation design and state of the art analytical methods. Surgical Oncology 7:71-76
21. Arad M, Elazar E, Shotan A, Klein R, Rabinowitz B (1996) Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Cardiology 87:12-17
22. Arakawa N, Nakamura M, Aoki H, Hiramori K (1994) Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 85:334-340
23. Benedict CR, Johnstone DE, Weiner DH et al (1994) Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators. J Am Coll Cardiol 23:1410-1420
24. Yamada Y, Goto J, Yokota M (1997) Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease. Cardiology 88:401-407
25. Karlsberg RP, Penoske PA, Cryer PE, Corr PB, Roberts R (1979) Rapid activation of the sympathetic nervous system following coronary occlusion: relationship to infarct size, site, and hemodynamic impact. Cardiovasc Res 13:523-531
26. Richardt G, Münch G, Neumann F-J, Rauch B, Kurz T (1997) Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction. Basic Res Cardiol 92:52-60
27. Wiese S, Breyer T, Dragu A et al (2000) Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium. Influence of angiotensin II and diastolic fiber length. Circulation 102:3074-3079